/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

S

Srilatha Edupuganti

Emory University(US)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

160

Papers

13.8K

Citations

45

h-index

89

i10-index

Srilatha Edupuganti is an academic researcher from Emory University. The author has contributed to research in topics: HIV Research and Treatment & SARS-CoV-2 and COVID-19 Research & HIV/AIDS drug development and treatment. The author has an h-index of 45, co-authored 136 publications.

ORCID: 0000-0001-6566-9969

Research Topics

HIV Research and Treatment SARS-CoV-2 and COVID-19 Research HIV/AIDS drug development and treatment COVID-19 Clinical Research Studies Influenza Virus Research Studies

Papers by this author

works

Rapid Generation of Neutralizing Antibody Responses in COVID-19 Patients

2020 · Cell Reports Medicine · 541 citations

https://doi.org/10.1016/j.xcrm.2020.100040

Mehul S. Suthar Matthew G. Zimmerman Robert C. Kauffman Grace Mantus

Origin and differentiation of human memory CD8 T cells after vaccination

2017 · Nature · 516 citations

https://doi.org/10.1038/nature24633

Rama Akondy Mark Fitch Srilatha Edupuganti Shu Yang

The Yellow Fever Virus Vaccine Induces a Broad and Polyfunctional Human Memory CD8+ T Cell Response

2009 · The Journal of Immunology · 344 citations

https://doi.org/10.4049/jimmunol.0803903

Rama Akondy Nathan D. Monson Joseph D. Miller Srilatha Edupuganti

Safety and immunogenicity of two heterologous HIV vaccine regimens in healthy, HIV-uninfected adults (TRAVERSE): a randomised, parallel-group, placebo-controlled, double-blind, phase 1/2a study

2020 · The Lancet HIV · 90 citations

https://doi.org/10.1016/s2352-3018(20)30229-0

Lindsey R. Baden Daniel J Stieh Michal Sarnecki Stephen R. Walsh

A Phase 2b Study to Evaluate the Safety and Efficacy of VRC01 Broadly Neutralizing Monoclonal Antibody in Reducing Acquisition of HIV-1 Infection in Women in Sub-Saharan Africa: Baseline Findings

2021 · JAIDS Journal of Acquired Immune Deficiency Syndromes · 45 citations

https://doi.org/10.1097/qai.0000000000002649

Nyaradzo Mgodi Simbarashe Takuva Srilatha Edupuganti Shelly Karuna

Tularemia vaccine: Safety, reactogenicity, “Take” skin reactions, and antibody responses following vaccination with a new lot of the Francisella tularensis live vaccine strain – A phase 2 randomized clinical Trial

2017 · Vaccine · 35 citations

https://doi.org/10.1016/j.vaccine.2017.07.024

Mark J. Mulligan Jack T. Stapleton Wendy A. Keitel Sharon E. Frey

Research topics

topics

HIV Research and Treatment

SARS-CoV-2 and COVID-19 Research

HIV/AIDS drug development and treatment

COVID-19 Clinical Research Studies

Influenza Virus Research Studies

Chat about Author

Papers

Chat

Click to start Chat